In this review we will examine in particular the role of NF-κB in some human tumor models such as triple negative breast cancer (TNBC), hepatocellular carcinoma (HCC) and acute myeloid leukemia (AML) characterized by high aggressiveness and little responsiveness to drug treatments. Here, NFKB1 is linked to hepatocellular carcinoma.